We are live on ! Find out more
RGNX icon

Regenxbio
RGNX

186 hedge funds and large institutions have $458M invested in Regenxbio in 2024 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 66 increasing their positions, 50 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 50

20% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 25

3% more funds holding

Funds holding: 181 → 186 (+5)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0.46% less ownership

Funds ownership: 88.82% → 88.36% (-0.46%)

10% less capital invested

Capital invested by funds: $512M → $458M (-$53.7M)

77% less call options, than puts

Call options by funds: $1.5M | Put options by funds: $6.66M

Holders
186
Holders Change
+5
Holders Change %
+2.76%
% of All Funds
2.67%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
30
Increased
66
Reduced
50
Closed
25
Calls
$1.5M
Puts
$6.66M
Net Calls
-$5.16M
Net Calls Change
-$4.96M

Top Buyers

Rank Fund Capital Flow
1
ACM
ADAR1 Capital Management
Texas
+$6.9M
2
IHAM
Integral Health Asset Management
New York
+$3.96M
3
RG
Redmile Group
California
+$3.94M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$3.82M
5
Bank of America
Bank of America
North Carolina
+$3.04M

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$9.08M
2
JP Morgan Chase
JP Morgan Chase
New York
-$6.52M
3
MB
MPM BioImpact
Massachusetts
-$6.18M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$3.13M
5
AG
Artal Group
Luxembourg
-$2.92M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$2.74M -$553K -45,330 -15%
HF
27
HRT Financial
New York
$2.45M +$2.85M +233,999 New
AI
28
ArchPoint Investors
Florida
$2.35M – – –
Hudson Bay Capital Management
29
Hudson Bay Capital Management
Connecticut
$2.26M +$610K +50,000 +30%
Principal Financial Group
30
Principal Financial Group
Iowa
$2.25M -$135K -11,064 -5%
PAM
31
Panagora Asset Management
Massachusetts
$2.2M +$289K +23,667 +13%
Citadel Advisors
32
Citadel Advisors
Florida
$2.13M +$937K +76,839 +61%
Qube Research & Technologies (QRT)
33
Qube Research & Technologies (QRT)
United Kingdom
$2.04M +$1.03M +84,092 +76%
ECM
34
ExodusPoint Capital Management
New York
$1.98M +$2.31M +189,099 New
Deutsche Bank
35
Deutsche Bank
Germany
$1.94M +$325K +26,679 +17%
HWAM
36
Hennion & Walsh Asset Management
New Jersey
$1.59M +$214K +17,525 +13%
Stifel Financial
37
Stifel Financial
Missouri
$1.57M +$214K +17,563 +13%
Macquarie Group
38
Macquarie Group
Australia
$1.56M – – –
Invesco
39
Invesco
Georgia
$1.43M -$162K -13,248 -9%
Acadian Asset Management
40
Acadian Asset Management
Massachusetts
$1.4M +$1.12M +91,525 +216%
Two Sigma Investments
41
Two Sigma Investments
New York
$1.32M -$656K -53,807 -30%
SSA
42
Schonfeld Strategic Advisors
New York
$1.31M +$921K +75,512 +154%
Legal & General Group
43
Legal & General Group
United Kingdom
$1.23M +$1.8K +148 +0.1%
Barclays
44
Barclays
United Kingdom
$1.22M +$828K +67,948 +141%
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$1.21M -$42.7K -3,501 -3%
N
46
Nuveen
North Carolina
$1.18M – – –
UBS Group
47
UBS Group
Switzerland
$1.17M +$102K +8,355 +8%
MCM
48
Moore Capital Management
New York
$1.05M – – –
Mirae Asset Global ETFs Holdings
49
Mirae Asset Global ETFs Holdings
Hong Kong
$1.03M -$148K -12,100 -11%
WG
50
Winton Group
United Kingdom
$1.02M +$245K +20,096 +26%
1
2
3 4 5

RGNX Hedge Fund Activity: Q3 2024 in Review

186 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q3 2024, worth a combined $458M — down 10% from $512M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new RGNX positions and 25 closed out — a net gain of 5 holders — while 66 added to existing stakes and 50 trimmed.

The largest buyer was ADAR1 Capital Management, adding an estimated $6.9M. The largest seller was Vanguard Group, cutting an estimated $9.08M.

  • 186 institutional investors held Regenxbio (RGNX) as of Q3 2024, up from 181 in Q2 2024.
  • Funds reported $458M of Regenxbio stock for Q3 2024, down 10% quarter-over-quarter.
  • 30 funds opened new Regenxbio positions in Q3 2024 and 25 closed out, a net change of +5 holders.
  • The largest Regenxbio buyer in Q3 2024 was ADAR1 Capital Management, an estimated $6.9M added.
  • The largest Regenxbio seller in Q3 2024 was Vanguard Group, an estimated $9.08M sold.

Based on aggregated 13F filings for Q3 2024.